CopyFind
Metocap AM Tablet
medicine 📍 IN

Metocap AM Tablet

75,50 ₹

Аналоги Metocap AM Tablet

Знайдіть доступніші аналоги та дженерики для Metocap AM Tablet.

Інгредієнти

Активний інгредієнт: Amlodipine; Metoprolol Succinate


Опис товару

About Metocap AM Tablet

Metocap AM Tablet is a medication containing the active ingredient Amlodipine, classified as Medication against high blood pressure. Amlodipine, sold under the brand name Norvasc among others, is a calcium channel blocker medication used to treat high blood pressure, coronary artery disease (CAD) and variant angina. It is taken orally.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Amlodipine besylate tablets are calcium channel blocker and may be used alone or in combination with other antihypertensive.
  • Used for: 1 ) о Amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Amlodipine, the active ingredient in Metocap AM Tablet, belongs to the Medication against high blood pressure class. 1 INDICATIONS AND USAGE Amlodipine besylate tablets are calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: •Hypertension ( 1. 1 ) о Amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Metocap AM Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Metocap AM Tablet for extended periods without medical advice.

Знайти в аптеках

Порівняйте місцеві ціни та відстань для Metocap AM Tablet.

Оцінки відвідувачів

Допоможіть іншим — оцініть корисність цієї сторінки.

Оцінок ще немає — будьте першим.